Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Reply: Rapid changes in practice make analysis of historical databases irrelevant for contemporary counselling.

Sunkara SK, LaMarca A, Polyzos NP, Seed PT, Khalaf Y.

Hum Reprod. 2017 Feb 25:1-2. doi: 10.1093/humrep/dex039. [Epub ahead of print] No abstract available.

PMID:
28333227
2.

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study.

Orkin C, DeJesus E, Ramgopal M, Crofoot G, Ruane P, LaMarca A, Mills A, Vandercam B, de Wet J, Rockstroh J, Lazzarin A, Rijnders B, Podzamczer D, Thalme A, Stoeckle M, Porter D, Liu HC, Cheng A, Quirk E, SenGupta D, Cao H.

Lancet HIV. 2017 Mar 1. pii: S2352-3018(17)30031-0. doi: 10.1016/S2352-3018(17)30031-0. [Epub ahead of print]

PMID:
28259777
3.

Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study.

DeJesus E, Ramgopal M, Crofoot G, Ruane P, LaMarca A, Mills A, Martorell CT, de Wet J, Stellbrink HJ, Molina JM, Post FA, Valero IP, Porter D, Liu Y, Cheng A, Quirk E, SenGupta D, Cao H.

Lancet HIV. 2017 Mar 1. pii: S2352-3018(17)30032-2. doi: 10.1016/S2352-3018(17)30032-2. [Epub ahead of print]

PMID:
28259776
4.

Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas.

Lamarca A, Walter T, Pavel M, Borbath I, Freis P, Nuñez B, Childs A, McNamara MG, Hubner RA, Garcia-Carbonero R, Meyer T, Valle JW, Barriuso J.

J Natl Cancer Inst. 2017 Jan 27;109(5). pii: djw277. doi: 10.1093/jnci/djw277. Print 2017 Jan.

PMID:
28130474
5.

Elderly patients diagnosed with hepatopancreatobiliary malignancies: A challenge beyond resection.

Lamarca A, Pihlak R, Frizziero M, McNamara MG, Hubner RA, Valle JW.

Cancer. 2017 Mar 1;123(5):888-890. doi: 10.1002/cncr.30502. Epub 2017 Jan 6. No abstract available.

PMID:
28061007
6.

HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?

Galdy S, Lamarca A, McNamara MG, Hubner RA, Cella CA, Fazio N, Valle JW.

Cancer Metastasis Rev. 2016 Dec 15. [Epub ahead of print]

PMID:
27981460
8.

Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.

Clay V, Papaxoinis G, Sanderson B, Valle JW, Howell M, Lamarca A, Krysiak P, Bishop P, Nonaka D, Mansoor W.

Clin Transl Oncol. 2016 Nov 15. [Epub ahead of print]

PMID:
27848218
9.

Telotristat ethyl: a new option for the management of carcinoid syndrome.

Lamarca A, Barriuso J, McNamara MG, Hubner RA, Valle JW.

Expert Opin Pharmacother. 2016 Dec;17(18):2487-2498. Epub 2016 Nov 16. Review.

PMID:
27817224
10.

Live birth and perinatal outcomes following stimulated and unstimulated IVF: analysis of over two decades of a nationwide data.

Sunkara SK, LaMarca A, Polyzos NP, Seed PT, Khalaf Y.

Hum Reprod. 2016 Oct;31(10):2261-7. doi: 10.1093/humrep/dew184. Epub 2016 Sep 2.

PMID:
27591229
11.

Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery.

Slagter AE, Ryder D, Chakrabarty B, Lamarca A, Hubner RA, Mansoor W, O'Reilly DA, Fulford PE, Klümpen HJ, Valle JW, McNamara MG.

Surg Oncol. 2016 Sep;25(3):223-8. doi: 10.1016/j.suronc.2016.05.019. Epub 2016 May 26.

PMID:
27566026
12.

Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib.

Lamarca A, Abdel-Rahman O, Salu I, McNamara MG, Valle JW, Hubner RA.

Clin Transl Oncol. 2017 Mar;19(3):364-372. doi: 10.1007/s12094-016-1537-6. Epub 2016 Aug 19.

PMID:
27541594
13.

Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy.

Lamarca A, Rigby C, McNamara MG, Hubner RA, Valle JW.

World J Gastroenterol. 2016 Jul 14;22(26):6065-75. doi: 10.3748/wjg.v22.i26.6065.

14.

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors.

Fotouhi O, Kjellin H, Larsson C, Hashemi J, Barriuso J, Juhlin CC, Lu M, Höög A, Pastrián LG, Lamarca A, Soto VH, Zedenius J, Mendiola M, Lehtiö J, Kjellman M.

J Clin Endocrinol Metab. 2016 Oct;101(10):3616-3627. Epub 2016 Jul 26.

15.

Ki-67 index and response to chemotherapy in patients with neuroendocrine tumours.

Childs A, Kirkwood A, Edeline J, Luong TV, Watkins J, Lamarca A, Alrifai D, Nsiah-Sarbeng P, Gillmore R, Mayer A, Thirlwell C, Sarker D, Valle JW, Meyer T.

Endocr Relat Cancer. 2016 Jul;23(7):563-70. doi: 10.1530/ERC-16-0099.

PMID:
27412968
16.

Hepatocellular carcinoma: Exploring the impact of ethnicity on molecular biology.

Lamarca A, Mendiola M, Barriuso J.

Crit Rev Oncol Hematol. 2016 Sep;105:65-72. doi: 10.1016/j.critrevonc.2016.06.007. Epub 2016 Jun 16. Review.

PMID:
27372199
17.

Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?

Lamarca A, Elliott E, Barriuso J, Backen A, McNamara MG, Hubner R, Valle JW.

Cancer Treat Rev. 2016 Mar;44:26-41. doi: 10.1016/j.ctrv.2016.01.005. Epub 2016 Jan 25. Review.

PMID:
26855376
18.

18F-FLT PET imaging of cellular proliferation in pancreatic cancer.

Lamarca A, Asselin MC, Manoharan P, McNamara MG, Trigonis I, Hubner R, Saleem A, Valle JW.

Crit Rev Oncol Hematol. 2016 Mar;99:158-69. doi: 10.1016/j.critrevonc.2015.12.014. Epub 2015 Dec 29. Review.

PMID:
26778585
19.

"If You Prick Us, Do We Not Bleed?" Whom Should We Choose?

McNamara MG, Lamarca A, Hubner RA, Valle JW.

J Clin Oncol. 2016 Feb 10;34(5):513-4. doi: 10.1200/JCO.2015.63.4576. Epub 2016 Jan 4. No abstract available.

PMID:
26729429
20.

Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours.

Monaghan PJ, Lamarca A, Valle JW, Hubner RA, Mansoor W, Trainer PJ, Darby D.

Clin Endocrinol (Oxf). 2016 Mar;84(3):348-52. doi: 10.1111/cen.12985. Epub 2015 Dec 24.

PMID:
26608723

Supplemental Content

Loading ...
Support Center